NCT01445535 2021-11-03Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Completed15 enrolled 18 charts
NCT00045500 2015-04-30UCN-01 and Prednisone in Treating Patients With Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Completed
NCT00004232 2012-06-01Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerNorthwestern UniversityPhase 1 Completed